Our Mission
At Infiniplex LTD., our aim is to make preemptive, preventive, and follow-up cancer screenings affordable and accessible to everyone by utilizing routine blood testing to screen for genetic tumor biomarkers.
To leverage the power of routine blood testing to screen for genetic tumor mutations & to provide
Accessible Affordable Personalized Innovative
tool for monitoring cancer treatments.
About Infiniplex
Infiniplex is an Israeli startup company dedicated to revolutionizing cancer treatment monitoring using state-of-the-art technologies. Our team is driven by passion and a relentless pursuit of excellence. We cultivate an environment that encourages ambition, drive, and a willingness to accept constructive feedback. Together, we are pushing the boundaries of innovation and aiming to make a profound impact in the battle against cancer.
Infiniplex Technology
We use qPCR (quantitative Real Time PCR) technology and novel primers that selectively amplify mutated DNA fragments enables the detection of dozens of mutations in various cancer types in a single test. Those primes are being designed by a propriety AI-based system that was developed by our multidisciplinary teams of scientists and software engineers.
Sampling
EXTRACTING
Analyzing
Testing
Infiniplex Product
Our product utilizes DNA that freely circulates in the bloodstream (cell-free DNA, cfDNA) as a non-invasive and real-time biomarker of cancer. Using a multiplexing method, it can identify dozens of mutations in various cancer types in a single test.
It provides the solution for increasing efficiency and specificity to detect mutations in cfDNA and selectively amplify the mutated DNA fragment, identifying its presence in the sample.
